OCT 24, 2019 9:43 PM PDT

Patients can Self-Inject Easily Using an Integrated Pre-Filled Syringe and Autoinjector

WRITTEN BY: Nupur Srivastava

The patients suffering from chronic disease require a regular dose of medicines, either orally or as injections. The patients prefer the self-injection method as it is easy to use, cost-effective, and prevents a monthly visit to the specialists.

Because chronic diseases require repeated dosing of medicines, the market for self-injections grew at over 22% per year towards nearly $80 billion by 2022.

“This move towards injection of biologics at home is a clear trend in our society and our industry, and it presents a clear challenge for device developers,” says John A. Merhige, Chief Commercial Officer, Credence MedSystems, Inc.

Video courtesy: Dove Medical Press 

Becton, Dickinson, and Company (BD) is a global leader in medical technology and self-injection systems. BD announced the launch of Intevia at Parental Drug Association’s (PDA) 2019 Universe of Pre-Filled Syringes and Injection Devices conference held in Gothenburg, Sweden. BD Intevia is a 1mL two-step integrated platform device that combines both an autoinjector and a pre-fillable syringe in one system (Image 1 and a Video). The system favorably optimizes patient self-injections with high-viscous drugs and therapies. 

Peter Nolan, Worldwide President, BD Medical - Pharmaceutical Systems, said: “BD Intevia is a new generation of BD autoinjectors that will help drug manufacturers seamlessly enhance drug delivery experience.” “For the patient, the platform technology is designed to promote patient ease of use when self-injecting, and it is supported by BD’s worldwide clinical injection expertise harnessing the latest research in drug delivery technology,” he added.

Image 1: The features of BD Intevia

The latest validation study participants highly rated BD Intevia autoinjector-prefill syringe and switching to the integrated disposable system for key product attributes as:

  • Overall acceptance, and
  • Confidence to control the start of injection.

Source: MarketSearchEngine, BD Intevia

About the Author
You May Also Like
MAR 24, 2020
Clinical & Molecular DX
Ultra sensitive cancer diagnostic detects DNA "fingerprints" in liquid biopsies
MAR 24, 2020
Ultra sensitive cancer diagnostic detects DNA "fingerprints" in liquid biopsies
  Researchers from the Broad and Dana-Farber Cancer Institutes have developed a diagnostic technology that can moni ...
MAR 24, 2020
Genetics & Genomics
Crumpling Graphene Makes It an Ultra-Sensitive Biosensor
MAR 24, 2020
Crumpling Graphene Makes It an Ultra-Sensitive Biosensor
Liquid biopsies often need to make many copies of RNA or DNA before they are detectable. New research aims to change tha ...
APR 14, 2020
Immunology
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
APR 14, 2020
Immunotherapy Shows Promise, Destroys Metastatic Brain Tumors
Lung cancer is the leading cause of death in both men and women in the U.S., with smokers bearing an elevated risk of th ...
APR 21, 2020
Clinical & Molecular DX
New Diagnostic FET-based Biosensor Enables Rapid Detection of SARS-CoV-2
APR 21, 2020
New Diagnostic FET-based Biosensor Enables Rapid Detection of SARS-CoV-2
The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the World’s attention. COVID- ...
JUN 09, 2020
Cell & Molecular Biology
Custom Manufacturing: Translating Research into Product
JUN 09, 2020
Custom Manufacturing: Translating Research into Product
Scientists around the world are focusing their energy and resources on translating advances made in clinical research in ...
JUN 07, 2020
Genetics & Genomics
An Imaging Tool That Could Speed the Diagnosis of Rare Diseases
JUN 07, 2020
An Imaging Tool That Could Speed the Diagnosis of Rare Diseases
When children have a rare genetic disease and do not have access to whole-genome sequencing and the analysis it requires ...
Loading Comments...